129 related articles for article (PubMed ID: 21676446)
1. Polymorphisms in the P450 c17 (17-hydroxylase/17, 20-Lyase) gene: association with estradiol and testosterone concentration in hypospadias.
Yadav CS; Bajpai M; Kumar V; Datta SK; Gupta P; Ahmed RS; Banerjee BD
Urology; 2011 Oct; 78(4):902-7. PubMed ID: 21676446
[TBL] [Abstract][Full Text] [Related]
2. [Association between polymorphism of CYP17 gene and serum hormone concentrations in aged men].
Wang JQ; Gu X; Chen JC; Sun XQ; Mu HT; Wei ZH; Li M; Xin DQ; Na YQ
Zhonghua Nan Ke Xue; 2005 Jun; 11(6):442-4. PubMed ID: 15999490
[TBL] [Abstract][Full Text] [Related]
3. Hypospadias risk and polymorphism in SRD5A2 and CYP17 genes: case-control study among Indian children.
Samtani R; Bajpai M; Vashisht K; Ghosh PK; Saraswathy KN
J Urol; 2011 Jun; 185(6):2334-9. PubMed ID: 21511288
[TBL] [Abstract][Full Text] [Related]
4. The relationship between müllerian inhibiting substance and androgens in boys with hypospadias.
Austin PF; Siow Y; Fallat ME; Cain MP; Rink RC; Casale AJ
J Urol; 2002 Oct; 168(4 Pt 2):1784-8; discussion 1788. PubMed ID: 12352359
[TBL] [Abstract][Full Text] [Related]
5. Association of serum sex steroid levels and bone mineral density with CYP17 and CYP19 gene polymorphisms in postmenopausal women in Turkey.
Yilmaz MB; Pazarbasi A; Guzel AI; Kocaturk-Sel S; Kasap H; Kasap M; Urunsak IF; Basaran S; Alptekin D; Demirhan O
Genet Mol Res; 2011 Sep; 10(3):1999-2008. PubMed ID: 21948762
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women.
Somner J; McLellan S; Cheung J; Mak YT; Frost ML; Knapp KM; Wierzbicki AS; Wheeler M; Fogelman I; Ralston SH; Hampson GN
J Clin Endocrinol Metab; 2004 Jan; 89(1):344-51. PubMed ID: 14715870
[TBL] [Abstract][Full Text] [Related]
7. A clinical study on sex hormone levels and CYP17-34T/C polymorphism in hypospadias or cryptorchidism.
Shu L; Yuan Z; He X; Han Z; Yang F; Xiao P; Chen L
Panminerva Med; 2024 Jun; 66(2):217-218. PubMed ID: 33765762
[No Abstract] [Full Text] [Related]
8. CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.
Verla-Tebit E; Wang-Gohrke S; Chang-Claude J
Breast Cancer Res; 2005; 7(4):R455-64. PubMed ID: 15987450
[TBL] [Abstract][Full Text] [Related]
9. CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients.
Chakraborty A; Murthy NS; Chintamani C; Bhatnagar D; Mohil RS; Sharma PC; Saxena S
J Hum Genet; 2007; 52(2):159-165. PubMed ID: 17235448
[TBL] [Abstract][Full Text] [Related]
10. The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men.
Allen NE; Forrest MS; Key TJ
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):185-9. PubMed ID: 11303586
[TBL] [Abstract][Full Text] [Related]
11. CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility.
Tüzüner BM; Oztürk T; Kisakesen HI; Ilvan S; Zerrin C; Oztürk O; Isbir T
In Vivo; 2010; 24(1):71-4. PubMed ID: 20133979
[TBL] [Abstract][Full Text] [Related]
12. A common promotor variant in the cytochrome P450c17alpha (CYP17) gene is associated with bioavailability testosterone levels and bone size in men.
Zmuda JM; Cauley JA; Kuller LH; Ferrell RE
J Bone Miner Res; 2001 May; 16(5):911-7. PubMed ID: 11341336
[TBL] [Abstract][Full Text] [Related]
13. Association of vitamin D receptor and 17 hydroxylase gene polymorphisms with benign prostatic hyperplasia and benign prostatic enlargement.
Schatzl G; Gsur A; Bernhofer G; Haidinger G; Hinteregger S; Vutuc C; Haitel A; Micksche M; Marberger M; Madersbacher S
Urology; 2001 Mar; 57(3):567-72. PubMed ID: 11248649
[TBL] [Abstract][Full Text] [Related]
14. Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5'-UTR in patients with polycystic ovarian syndrome.
Marszalek B; Laciński M; Babych N; Capla E; Biernacka-Lukanty J; Warenik-Szymankiewicz A; Trzeciak WH
Gynecol Endocrinol; 2001 Apr; 15(2):123-8. PubMed ID: 11379008
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.
Habuchi T; Liqing Z; Suzuki T; Sasaki R; Tsuchiya N; Tachiki H; Shimoda N; Satoh S; Sato K; Kakehi Y; Kamoto T; Ogawa O; Kato T
Cancer Res; 2000 Oct; 60(20):5710-3. PubMed ID: 11059764
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism of CYP17 and breast cancer risk in Korean women.
Shin MH; Lee KM; Yang JH; Nam SJ; Kim JW; Yoo KY; Park SK; Noh DY; Ahn SH; Kim B; Kang D
Exp Mol Med; 2005 Feb; 37(1):11-7. PubMed ID: 15761247
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations.
Feigelson HS; Shames LS; Pike MC; Coetzee GA; Stanczyk FZ; Henderson BE
Cancer Res; 1998 Feb; 58(4):585-7. PubMed ID: 9485002
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in the CYP17 gene and recurrent spontaneous abortions.
Litridis I; Kapnoulas N; Natisvili T; Agiannitopoulos K; Peraki O; Ntostis P; Pantos K; Lamnissou K
Arch Gynecol Obstet; 2011 Feb; 283(2):289-93. PubMed ID: 20069306
[TBL] [Abstract][Full Text] [Related]
19. The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer.
Haiman CA; Stampfer MJ; Giovannucci E; Ma J; Decalo NE; Kantoff PW; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):743-8. PubMed ID: 11440959
[TBL] [Abstract][Full Text] [Related]
20. A polymorphism in the CYP17 gene relates to the risk of recurrent pregnancy loss.
Sata F; Yamada H; Yamada A; Kato EH; Kataoka S; Saijo Y; Kondo T; Tamaki J; Minakami H; Kishi R
Mol Hum Reprod; 2003 Nov; 9(11):725-8. PubMed ID: 14561815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
